Biolex Therapeutics' Debt - III Round

Biolex Therapeutics raised a round of funding on June 09, 2011.

Biolex Therapeutics is a clinical-stage biopharmaceutical company that uses the LEX System to develop follow-on biologics, hard-to-make therapeutic proteins and monoclonal antibodies that have been op…

Articles about Biolex Therapeutics' Debt - III Round: